Latest news with #cloning
Yahoo
2 days ago
- Yahoo
Ongoing vehicle fraud, theft case under investigation; two arrested, sheriff's office says
ST. LUCIE COUNTY − Two people were arrested June 17 as St. Lucie County Sheriff's officials investigated a business as part of what the agency described as an 'ongoing vehicle fraud and theft case,' the agency stated. Sheriff's officials June 18 identified the business as Drizzle Drip Mobile Detailing, LLC. Sheriff's officials reported executing a search warrant June 17 at a home in the 200 block of Southwest Eyerly Avenue. Investigators found items including five vehicles, one of which they said was 'cloned.' Cloning a vehicle refers to copying a vehicle identification number, or VIN, from a legally registered vehicle and putting it on a salvaged or stolen vehicle to disguise the vehicle's true identity, said Lt. Andrew Bolonka, sheriff's spokesperson. 'Upon uncovering the vehicle's true identification number, it was revealed that the vehicle had been reported stolen to the Orange County Sheriff's Office in July 2024,' the sheriff's office stated. According to the sheriff's office, the case has extended into Indian River County with sheriff's investigators there executing search warrants. 'These actions are part of a broader, multi-agency effort to uncover the scope of the fraudulent activities,' the St. Lucie County Sheriff's Office stated. Sheriff's officials reported arresting as Cortez Rashad Ash and Josuaire Pierre, both 33 and of Port St. Lucie. 'Extremely hardworking': Man, 30, dead after motorcycle crash in PSL remembered Fatal crash in Fort Pierce: Driver dead after seven vehicle crash on U.S. 1 identified as 70-year-old man Each was arrested on a grand theft motor vehicle charge, while Pierre also was arrested on a driving while license revoked or suspended charge, records show. Ash was released early June 18 from the St. Lucie County Jail on $2,500 bond, while Pierre was released on $3,000 bond, according to sheriff's records. Those who bought a vehicle from Ash or Pierre or Drizzle Drip Mobile Detailing, LLC, are asked to contact sheriff's officials at 772-462-7300 or Detective Jay Carver at Carverj@ Will Greenlee is a breaking news reporter for TCPalm. Follow Will on X @OffTheBeatTweet or reach him by phone at 772-267-7926. E-mail him at This article originally appeared on Treasure Coast Newspapers: Two arrested in 'ongoing' vehicle fraud, theft case in SLC
News.com.au
2 days ago
- Entertainment
- News.com.au
Ozzy Osbourne urges fans to clone him as he sells his DNA
The move has sparked hopes the Black Sabbath frontman could be cloned in the future, with the limited edition cans, called Infinite Ozzy, already believed to have sold out. Beverage business Liquid Death confirmed a deal had been made with the music icon. "Ozzy Osbourne is 1 of 1," the company said in a statement. "But we're selling his actual DNA so you can recycle him forever.". In an advert to promote the product, the 76-year-old rocker is featured drinking from the cans before crushing them with his hands. The cans are then placed in a sealed container.
Irish Times
4 days ago
- Health
- Irish Times
Tusla copy-and-paste process could lead to false claims on children's files, Aontú claim
A review must be carried out on Tusla files amid concerns that incorrect information has been copied on to children's case notes, according to Aontú . The party's leader, Peadar Tóibín , said he was concerned that false claims on files could lead to children being 'wrongly or unnecessarily taken into care'. Tusla staff handling child welfare concerns have previously used a process called 'cloning' – where information about one child is copied on to the form relating to a sibling. Earlier this year, the Health Information and Quality Authority ( Hiqa ) published a review that it carried out on Tusla services in the midlands. The review, which was sparked by concerns about the inaccuracy of information on child and family agency casework in Laois, Longford, Offaly and Westmeath, found that staff were using 'cloning' on children's files. This is when certain information is included on the files of each child in a family, even when it may not be accurate. READ MORE The Hiqa report said: 'The process of cloning information from one sibling to another meant that some children's files reviewed did not contain accurate information about the child, but was copied information about a sibling, which meant it did not accurately reflect that individual child's circumstances or level of risk.' During the inspection, the midlands service was found to be not compliant with a standard which ensures relevant information is used 'to plan and deliver effective child-protection and welfare services'. [ Tusla's failure to provide secure care beds for children at risk an 'affront to rule of law', judge says Opens in new window ] Mr Tóibín described the process of 'cloning' as effectively 'copying and pasting'. 'This is a very significant problem – Tusla have openly admitted to me that there are 'copying and pasting' errors on files relating to the process of taking children into State care, off their parents.' The Aontú leader has been asking Tulsa about the practice of copying inaccurate information on to files after becoming aware of a case where a file on a woman included a false assertion that she had a problem with alcohol when she does not drink. The case, which was reported on by The Irish Times in 2021 , involved a number of 'clear errors' on the family's file. Tusla has since apologised to the family. 'Tusla refuse to tell me how many others are affected, and say they are training staff in how to copy and paste accurately. This isn't good enough,' Mr Tóibín said. 'Aontú believe there must be a review of all files to determine how many others contain untruths and inaccuracies, and indeed how many other children have been wrongly or unnecessarily taken into care.' Tusla previously said it had taken action and increased staff training in order to avoid mistakes being copied on to files. In response to the Hiqa review, Tusla said 'workers have been advised of the importance of ensuring accuracy of information specific to each child when cloning records. Team meetings and the supervision process will be utilised to continue to reinforce this.'
Medscape
06-06-2025
- Health
- Medscape
Medscape at 30: Three Decades of Amazing Breakthroughs
Medscape turns 30 in 2025. As part of the Medscape 2050 project speculating on what the field will look like 25 years from now, we're looking back at medical history as told through Medscape news coverage. A walk down memory lane, for sure, but also a celebration of the breakthroughs, headlines, and reporting that helped define medicine since 1995. July 5, 1996: Dolly the Sheep Cloned The birth of the first cloned animal led to some interesting cloning coverage over the years, whether from claims of a cloned human baby, ethical concerns surrounding human cloning, and advances in animal cloning as more than just a curiosity: Single Genetic Difference May Make Humans Easier to Clone Knockout Pigs Heralded as Future Organ Source FDA: Meat of Cloned Animals Safe to Eat 1998: Discovery of Human Embryonic Stem Cells A groundbreaking and polarizing discovery. Just over a year later, Medscape would look at the fallout, and advances would attempt to eliminate ethical concerns by tricking mouse and human cells to exhibit all the traits of embryonic stem cells. Coverage would span many conditions over the years: Is New Stem Cell Research Major Step Toward Diabetes Cure? Stem Cell Therapy Among Hot Topics at AAO 2017 Promising New Data on Stem Cell Therapy for Parkinson's 1997: da Vinci Robotic Surgical System Begins Development Minimally invasive robotic surgery via the da Vinci system was approved by the FDA in 2000, and by 2011, it was in use in more than 2000 hospitals around the world. Between 2011 and 2012, however, adverse event reports rose 34%, prompting this detailed Medscape slideshow, Robotic Surgery: Too Much, Too Soon? 2000: First Draft of the Human Genome Announced It wasn't perfect, it had gaps and wasn't fully understood, but the turn of the century marked the first map of the human genome, paving the way for what we now see as precision and personalized medicine. In 2020, Medscape commissioned a thorough charting of the genome over its first 20 years to see what grew from that first announcement. Early 2000s: Rise of Direct-to-Consumer (DTC) Genetic Testing (eg, 23andMe) Inexpensive genetic testing led to the advent of offering tests to consumers, and the most famous purveyor, 23andMe, debuted in 2006. This marked a shift in how people access and interpret genetic data — and raised concerns. It's been a bumpy ride: Ethical Considerations in DTC Genetic Testing 23andMe Relaunches Lower-Risk DTC Genetic Tests FDA OK's First DTC Genetic Risk Tests 23andMe Notifies Customers of Data Breach Into Its 'DNA Relatives' Feature 23andMe's Business Woes Raise Genetic Data Privacy Concerns: Ethicist 2009: Electronic Health Record (EHR) Adoption Incentivized by HITECH Act EHRs, now ubiquitous, started slow in 2009, with one report estimating adoption in US hospitals at less than 2%. All that changed of course, with Medscape eventually releasing annual reports on physicians and EHRs. And in 2024, we even asked if physicians should be compensated for their time using EHRs. Don't Get Too Hung Up on 'Meaningful Use' in an EHR EHR Adoption Grows Rapidly in Office-Based Physician Groups 2012: CRISPR-Cas9 Gene Editing Discovered 2016: First CRISPR Clinical Trial in Humans Gene editing, and the ethical arguments that went with it, took the medical world by storm a little over a decade ago. Medscape has been covering its potential therapeutic (and controversial) applications ever since including the 2018 birth of 'gene-edited babies' in China. 5 Things to Know About CRISPR New CRISPR Tools More Precise, but Targeting Mishaps a Worry CRISPR Gene Editing in Limelight at ASHG 2016 Bioethicist: History Tells Us CRISPR Fears Are Overblown 2016: Semaglutide Shows Superior Glucose Control and Weight Loss in SUSTAIN-6 Trials The hype begins. Not only shown effective for glucose control, semaglutide also demonstrated marked cardiovascular risk reduction in 2016. While that was nearly 10 years ago, it feels like we haven't had a day without GLP-1 news since. Oral GLP-1 Agonists Could Be Game Changers for Obesity Treating Obesity: Will New Miracle Drugs End the Crisis? GLP-1s Treat and Even Reverse Some Forms of Liver Disease GLP-1 Agonists Reduce Recurrent Atrial Fibrillation July-October 2017: CAR T-Cell Therapy Approved for Leukemia The FDA approved tisagenlecleucel-T (Kymriah, Novartis) and soon after a xicabtagene ciloleucel (Yescarta, Kite Pharma), the first two CAR T-cell therapies in 2017, opening the door for personalized cancer treatment and further progress beyond treating blood cancers. CARs Motor Through Leukemia, Part 2: 'Landscape Changing' CAR T Cells and Beyond: Breakthroughs and Challenges Ahead Outpatient CAR T: Safe, Effective, Accessible Next-Gen CAR T-Cell Therapy: Expanding Beyond Blood Cancers December 2020: mRNA Vaccines Approved After effectiveness of the Pfizer and Moderna COVID vaccines was documented, the FDA granted emergency use of both vaccines within a week of each other. This opened the door for further mRNA usage, including potential cancer vaccines. 4 Things to Know About Moderna's mRNA Cancer Vaccine New mRNA Vaccines in Development for Cancer and Infections 'Encouraging' Early Data for mRNA Vaccine in Glioblastoma New mRNA Vaccine May Shield Against C difficile Infections 2023: FDA Approvals in Medical Artificial Intelligence (AI), Especially Diagnostics, Increase While AI was not invented in 2023, that year became a tipping point in everything AI — from diagnostics to drug development to medical scribes, inspiring the first Medscape Physicians and AI Report, done annually since. A sampling of the flood of Medscape coverage: Minding the Machine: Assessing the Case for AI Regulations in Healthcare Harnessing FDA-Approved AI Technologies in Your Medical Practice The Protein Problem: The Unsolved Mystery of AI Drug Dev This Bill Could Make It Legal for AI to Prescribe Medicine AI vs Physicians in 2050: Happy Future or No Future?
Yahoo
01-06-2025
- General
- Yahoo
"Soulless, mindless entities": Trump shares QAnon conspiracy theory suggesting Biden is a clone
Posting to Truth Social late Saturday night, Donald Trump boosted a claim that former President Joe Biden was a clone. "There is no #JoeBiden - executed in 2020," the reshared post reads. "#Biden clones, doubles & robotic engineered soulless mindless entities are what you see. #Democrats don't know the difference." The claim that body doubles or clones have replaced some celebrities for nebulous and nefarious reasons holds some purchase among members of the far-right. And to give some credit to Trump, it's entirely possible that he skimmed the text and thought it aligned with his frequent claims that Biden was puppeteered throughout his second term. The president has been amplifying right-wing internet conspiracies for years. He gave subtle nods to QAnon, the online cult that believes Trump will usher in a great "storm" that will cleanse sex traffickers and child abusers from positions of power in the United States, while campaigning for a second term. His campaign elevated unfounded beliefs about gang and cartel activity in the country and raised the profile of an entirely fabricated claim that Haitian immigrants in Ohio were eating local pets. In the latter case, Trump's insistence that recently resettled Haitian immigrants were "eating the cats" and "eating the dogs" led to bomb threats in the city of Springfield. Still, delving into talks of cloning grown humans — something that is not scientifically possible in the present — is a big step into the murk of the GOP's tin-foil fringe.
